Satter Management Co., L.p. Buys Aadi Bioscience Inc, Sells Aerpio Pharmaceuticals Inc

Investment company Satter Management Co., L.p. (Current Portfolio) buys Aadi Bioscience Inc, sells Aerpio Pharmaceuticals Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Satter Management Co., L.p.. As of 2021Q3, Satter Management Co., L.p. owns 7 stocks with a total value of $146 million. These are the details of the buys and sells.

For the details of SATTER MANAGEMENT CO., L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/satter+management+co.%2C+l.p./current-portfolio/portfolio

These are the top 5 holdings of SATTER MANAGEMENT CO., L.P.
  1. American Well Corp (AMWL) - 6,300,773 shares, 39.29% of the total portfolio.
  2. Annexon Inc (ANNX) - 1,954,978 shares, 24.90% of the total portfolio.
  3. Aileron Therapeutics Inc (ALRN) - 16,609,449 shares, 11.60% of the total portfolio.
  4. Akebia Therapeutics Inc (AKBA) - 4,652,561 shares, 9.17% of the total portfolio.
  5. Aadi Bioscience Inc (AADI) - 374,785 shares, 7.53% of the total portfolio. New Position
New Purchase: Aadi Bioscience Inc (AADI)

Satter Management Co., L.p. initiated holding in Aadi Bioscience Inc. The purchase prices were between $0 and $32.66, with an estimated average price of $27.53. The stock is now traded at around $23.630000. The impact to a portfolio due to this purchase was 7.53%. The holding were 374,785 shares as of 2021-09-30.

Sold Out: Aerpio Pharmaceuticals Inc (ARPO)

Satter Management Co., L.p. sold out a holding in Aerpio Pharmaceuticals Inc. The sale prices were between $25.65 and $41.85, with an estimated average price of $31.47.



Here is the complete portfolio of SATTER MANAGEMENT CO., L.P.. Also check out:

1. SATTER MANAGEMENT CO., L.P.'s Undervalued Stocks
2. SATTER MANAGEMENT CO., L.P.'s Top Growth Companies, and
3. SATTER MANAGEMENT CO., L.P.'s High Yield stocks
4. Stocks that SATTER MANAGEMENT CO., L.P. keeps buying